2026-04-25T14:07:56Z https://www.pub.unibl.org/oai

oai:pub.unibl.org:29150 2026-03-26T04:43:28Z

Bevacizumab in combination with irinotecan and capecitabine as first-line tretment for mCRC-efficacy and safety https://www.unibl.org/sr-lat/fis/zaposlen/3512-sasa-jungic /unibl/author/G. Kecman-Malčić /unibl/author/Ivanka Rakita /unibl/author/D. Jovanović https://www.unibl.org/sr-lat/fis/zaposlen/3346-radoslav-gajanin /unibl/author/Zdravko Marić https://www.unibl.org/sr-lat/fis/zaposlen/3255-biljana-tubic https://www.unibl.org/sr-lat/fis/zaposlen/3371-zdenka-gojkovic 2014 Conference Paper text /unibl/sci/idNaucniRad:25640 https://dx.doi.org/https://doi.org/10.1093/annonc/mdu165.175 https://med.unibl.org Annals of Oncology Annals of Oncology https://www.pub.unibl.org/s/cir/item/29150